Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial

AIM OF THE STUDY: The aim of this trial was to compare overall survival (OS), disease-free survival (DFS), and toxicity of two adjuvant regimens in triple negative patients with Iranian ethnicity. MATERIAL AND METHODS: In a phase II trial, patients with previously untreated triple negative breaststr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Oncol (Pozn)
Hlavní autoři: Najafi, Safa, Payandeh, Mehrdad, Sadeghi, Masoud, Shafaei, Vahideh, Shojaiyan, Fateme, Abbasvandi, Fereshte
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2017
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385483/
https://ncbi.nlm.nih.gov/pubmed/28435404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2017.66661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky